Related Experiment Video

Updated: May 12, 2026

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
07:11

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Published on: October 28, 2020

2.8K

New Insights Into Genetic Right Ventricular Cardiomyopathies

Marta Garcia-Montero1, Yehia Fanous2, Andrew D Krahn3

  • 1Cardiovascular Genetics Centre and Electrophysiology Service, Montréal Heart Institute, Université de Montréal, Montréal, Québec, Canada.

The Canadian Journal of Cardiology
|February 16, 2025
PubMed

Insights

Arrhythmogenic right ventricular cardiomyopathy (ARVC) research has advanced significantly with gene identification and deep phenotyping. Gene-specific insights are paving the way for precision medicine in ARVC diagnosis and treatment.

Area of Science:

  • Cardiology
  • Genetics
  • Precision Medicine

Background:

  • Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart disease affecting the right ventricle.
  • Significant progress has been made in identifying ARVC-causing genes since 2000.
  • Deep phenotyping has enhanced understanding of ARVC's diverse clinical presentations.

Purpose of the Study:

  • To review the advancements in understanding arrhythmogenic right ventricular cardiomyopathy.
  • To highlight the impact of genotype-phenotype correlations on ARVC research.
  • To discuss the future of precision medicine in ARVC diagnosis and treatment.

Main Methods:

  • Review of genetic and phenotypic data in arrhythmogenic right ventricular cardiomyopathy.
  • Analysis of collaborative research efforts within the ARVC community.
  • Integration of cardiogenetic information for disease management.

Main Results:

  • Identification of numerous ARVC-associated genes has correlated with specific phenotypes.
  • Explosion of genotype and phenotype data has greatly advanced disease understanding.
  • Focus on gene-specific phenotypes aids in risk assessment and mitigation strategies.

Conclusions:

  • Gene-specific understanding is crucial for advancing precision medicine in ARVC.
  • Current knowledge supports improved diagnosis, natural history prediction, and targeted interventions.
  • The ARVC community is entering a new era focused on transforming patient outcomes through collaborative research and innovative therapies.

More Related Videos

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice10:18

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice

Published on: February 1, 2022

3.0K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.0K

Related Concept Videos

Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...